CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Teva Pharmaceuticals International GmbH v. Eli Lilly and Company

1:21-cv-10954

Overview

Case Number 1:21-cv-10954
Filing Date 2021-06-07
Status Terminated
Termination Date 2023-11-28
Court District Court, D. Massachusetts (mad)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand Plaintiff

Parties

Defendant

Eli Lilly and Company Operating Company

Represented By

10 Attorneys Listed

Andrea L. Martin

Burns & Levinson LLP

Tel: +1 (617) 345-3000
Fax: +1 (617) 345-3299

125 High Street, Boston, MA 02110

Alissa K. Lipton

Finnegan, Henderson, Farabow, Garrett & Dunner, LLP

Tel: +1 (617) 646-1643
Fax: +1 (617) 646-1666

Two Seaport Lane, 6th Flr., Boston, MA 02210-2001

Yoonjin Lee

Finnegan, Henderson, Farabow, Garrett & Dunner, LLP.

Tel: +1 (202) 408-4332

901 New York Ave NW, Washington, DC 20001

William B Raich

Finnegan Henderson Farabow Garrett & Dunner, LLP

Tel: +1 (202) 408-4054

901 New York Avenue, NW, Washington, DC 20001-4413

Michael R. Galgano

Finnegan, Henderson, Farabow, Garett & Dunner, LLP

Tel: +1 (202) 408-4153

901 New York Avenue NW, Washington, DC 20001

Mark J. Stewart

Eli Lilly and Company

Tel: +1 (317) 276-0280

Eli Lilly and Company, Lilly Corporate Center

Mark J. Feldstein

Finnegan, Henderson, Farabow, Garrett & Dunner, LLP.

Tel: +1 (202) 408-4092
Fax: +1 (202) 408-4400

901 New York Avenue, NW, Washington, DC 20001

Drew D. Christie

Finnegan, Henderson, Farabow, Garrett & Dunner, LLP.

Tel: +1 (571) 203-2732
Fax: +1 (202) 408-4400

Two Freedom Square, 11955 Freedom Drive

Danielle A. Duszczyszyn , I

Finnegan Henderson Farabow Garrett & Dunner, LLP

Tel: +1 (202) 408-4142

901 New York Avenue, NW, Washington, DC 20001-4413

Charles E. Lipsey

Finnegan,Henderson,Farabow,Garrett & Dunner, LLP.

Tel: +1 (571) 203-2700
Fax: +1 (202) 408-4400

1875 Explorer Street, Reston, VA 20190

Plaintiff

Teva Pharmaceuticals USA, Inc. Operating Company

Represented By

7 Attorneys Listed

Andrew S. McDonough

Goodwin Procter LLP

Tel: +1 (617) 570-1457

100 Northern Avenue, Boston, MA 02210

Alison Siedor

Goodwin Procter LLP (NY)

Tel: +1 (212) 813-8800

The New York Times Building, 620 Eighth Avenue

Natasha E. Daughtrey

Goodwin Procter LLP

Tel: +1 (213) 426-2500
Fax: +1 (213) 623-1673

601 S. Figueroa Street, Los Angeles, CA 90017-5704

Robert Frederickson , III

Goodwin Procter, LLP

Tel: +1 (617) 570-1000
Fax: +1 (617) 523-1231

100 Northern Avenue, Boston, MA 02210

Molly Grammel

Goodwin Procter, LLP

Tel: +1 (617) 570-1000

100 Northern Avenue, Boston, MA 02210

Elaine Herrmann Blais

Goodwin Procter, LLP

Tel: +1 (617) 570-1205
Fax: +1 (617) 523-1231

100 Northern Avenue, Boston, MA 02210

Douglas J. Kline

Goodwin Procter, LLP

Tel: +1 (617) 570-1000
Fax: +1 (617) 523-1231

100 Northern Avenue, Boston, MA 02210

Teva Pharmaceuticals International GmbH Operating Company

Represented By

7 Attorneys Listed

Andrew S. McDonough

Goodwin Procter LLP

Tel: +1 (617) 570-1457

100 Northern Avenue, Boston, MA 02210

Alison Siedor

Goodwin Procter LLP (NY)

Tel: +1 (212) 813-8800

The New York Times Building, 620 Eighth Avenue

Natasha E. Daughtrey

Goodwin Procter LLP

Tel: +1 (213) 426-2500
Fax: +1 (213) 623-1673

601 S. Figueroa Street, Los Angeles, CA 90017-5704

Robert Frederickson , III

Goodwin Procter, LLP

Tel: +1 (617) 570-1000
Fax: +1 (617) 523-1231

100 Northern Avenue, Boston, MA 02210

Molly Grammel

Goodwin Procter, LLP

Tel: +1 (617) 570-1000

100 Northern Avenue, Boston, MA 02210

Elaine Herrmann Blais

Goodwin Procter, LLP

Tel: +1 (617) 570-1205
Fax: +1 (617) 523-1231

100 Northern Avenue, Boston, MA 02210

Douglas J. Kline

Goodwin Procter, LLP

Tel: +1 (617) 570-1000
Fax: +1 (617) 523-1231

100 Northern Avenue, Boston, MA 02210

Court & Judges

Court

District Court, D. Massachusetts (mad)

Global Patent Family Cross-Litigation Radar

CasLoc 360° Radar

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

No Co-Pending Disputes Detected in Current Index

There are no other active filings for this patent family across our indexed PTAB, U.S. Court, UPC, or EPO databases.

Patents Involved

No asserted patent numbers detected in initial docket filings yet.

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

25

Dispositive

9

Granted

0

Denied

1

Pending / Review

24

Motions by Category

Procedural / Extension Motion 16 Motion to Dismiss (FRCP 12(b)(6)) 5 Motion to Dismiss 4

Key Dispositive Motions & Rulings

Motion to Dismiss Denied
Judge Allison D. Burroughs: MEMORANDUM AND ORDER on Motion to Dismiss entered.Lilly's motion to dismiss, [ECF No. 15 ], is DENIED.SO ORDERED.(McManus, Caetlin)
Entry #33 • 2022-03-15 Document →
Motion to Dismiss (FRCP 12(b)(6)) Pending / Under Review
SUR-REPLY to Motion re 15 MOTION TO DISMISS FOR FAILURE TO STATE A CLAIM filed by Teva Pharmaceuticals International GmbH, Teva Pharmaceuticals USA, Inc.. (Gram...
Entry #32 • 2021-11-09 Document →
Motion to Dismiss Pending / Under Review
Assented to MOTION for Leave to File a Sur-Reply Memorandum in Further Opposition to Motion to Dismiss by Teva Pharmaceuticals International GmbH, Teva Pharmace...
Entry #30 • 2021-11-03 Document →
Motion to Dismiss (FRCP 12(b)(6)) Pending / Under Review
REPLY to Response to 15 MOTION TO DISMISS FOR FAILURE TO STATE A CLAIM Leave to File Granted 10.28.21 filed by Eli Lilly and Company. (Martin, Andrea) (Entered:...
Entry #29 • 2021-11-02 Document →
Motion to Dismiss Pending / Under Review
Assented to MOTION for Leave to File Reply in support of Motion to Dismiss by Eli Lilly and Company.(Martin, Andrea) (Entered: 10/28/2021)
Entry #27 • 2021-10-28 Document →
Motion to Dismiss Pending / Under Review
Judge Allison D. Burroughs: ELECTRONIC ORDER entered granting 27 Assented to MOTION for Leave to File Reply in support of Motion to Dismiss ; Counsel using the ...
Entry #28 • 2021-10-28 Document →

Docket Entries

(90 total)
Pleading / Complaint

COMPLAINT against Eli Lilly and Company Filing fee: $ 402, receipt number 0101-8809234 (Fee Status: Filing Fee paid), filed by Teva Pharmaceuticals International GmbH, Teva Pharmaceuticals USA, Inc.. (Attachments: # 1 Civil Cover Sheet, # 2 Category Form, # 3 Exhibit 1, # 4 Exhibit 2, # 5 Exhibit 3, # 6 Exhibit 4, # 7 Exhibit 5, # 8 Exhibit 6, # 9 Exhibit 7, # 10 Exhibit 8, # 11 Exhibit 9, # 12 Exhibit 10, # 13 Exhibit 11, # 14 Exhibit 12, # 15 Exhibit 13, # 16 Exhibit 14, # 17 Exhibit 15, # 18 Exhibit 16, # 19 Exhibit 17, # 20 Exhibit 18, # 21 Exhibit 19, # 22 Exhibit 20, # 23 Exhibit 21, # 24 Exhibit 22, # 25 Exhibit 23, # 26 Exhibit 24, # 27 Errata 25, # 28 Exhibit 26, # 29 Exhibit 27, # 30 Exhibit 28, # 31 Exhibit 29, # 32 Exhibit 30, # 33 Exhibit 31, # 34 Exhibit 32, # 35 Exhibit 33, # 36 Exhibit 34, # 37 Exhibit 35, # 38 Exhibit 36, # 39 Exhibit 37, # 40 Exhibit 38, # 41 Exhibit 39, # 42 Exhibit 40, # 43 Exhibit 41, # 44 Exhibit 42, # 45 Exhibit 43, # 46 Exhibit 44, # 47 Exhibit 45, # 48 Exhibit 46, # 49 Exhibit 47, # 50 Exhibit 48)(Blais, Elaine) (Entered: 06/08/2021)

Entry #1 • 2021-06-08
1
Pleading / Complaint

COMPLAINT against Eli Lilly and Company Filing fee: $ 402, receipt number 0101-8809234 (Fee Status: Filing Fee paid), filed by Teva Pharmaceuticals International GmbH, Teva Pharmaceuticals USA, Inc.. (Attachments: # 1 Civil Cover Sheet, # 2 Category Form, # 3 Exhibit 1, # 4 Exhibit 2, # 5 Exhibit 3, # 6 Exhibit 4, # 7 Exhibit 5, # 8 Exhibit 6, # 9 Exhibit 7, # 10 Exhibit 8, # 11 Exhibit 9, # 12 Exhibit 10, # 13 Exhibit 11, # 14 Exhibit 12, # 15 Exhibit 13, # 16 Exhibit 14, # 17 Exhibit 15, # 18 Exhibit 16, # 19 Exhibit 17, # 20 Exhibit 18, # 21 Exhibit 19, # 22 Exhibit 20, # 23 Exhibit 21, # 24 Exhibit 22, # 25 Exhibit 23, # 26 Exhibit 24, # 27 Errata 25, # 28 Exhibit 26, # 29 Exhibit 27, # 30 Exhibit 28, # 31 Exhibit 29, # 32 Exhibit 30, # 33 Exhibit 31, # 34 Exhibit 32, # 35 Exhibit 33, # 36 Exhibit 34, # 37 Exhibit 35, # 38 Exhibit 36, # 39 Exhibit 37, # 40 Exhibit 38, # 41 Exhibit 39, # 42 Exhibit 40, # 43 Exhibit 41, # 44 Exhibit 42, # 45 Exhibit 43, # 46 Exhibit 44, # 47 Exhibit 45, # 48 Exhibit 46, # 49 Exhibit 47, # 50 Exhibit 48)(Blais, Elaine) (Entered: 06/08/2021)

Entry #1 • 2021-06-08
2
Pleading / Complaint

COMPLAINT against Eli Lilly and Company Filing fee: $ 402, receipt number 0101-8809234 (Fee Status: Filing Fee paid), filed by Teva Pharmaceuticals International GmbH, Teva Pharmaceuticals USA, Inc.. (Attachments: # 1 Civil Cover Sheet, # 2 Category Form, # 3 Exhibit 1, # 4 Exhibit 2, # 5 Exhibit 3, # 6 Exhibit 4, # 7 Exhibit 5, # 8 Exhibit 6, # 9 Exhibit 7, # 10 Exhibit 8, # 11 Exhibit 9, # 12 Exhibit 10, # 13 Exhibit 11, # 14 Exhibit 12, # 15 Exhibit 13, # 16 Exhibit 14, # 17 Exhibit 15, # 18 Exhibit 16, # 19 Exhibit 17, # 20 Exhibit 18, # 21 Exhibit 19, # 22 Exhibit 20, # 23 Exhibit 21, # 24 Exhibit 22, # 25 Exhibit 23, # 26 Exhibit 24, # 27 Errata 25, # 28 Exhibit 26, # 29 Exhibit 27, # 30 Exhibit 28, # 31 Exhibit 29, # 32 Exhibit 30, # 33 Exhibit 31, # 34 Exhibit 32, # 35 Exhibit 33, # 36 Exhibit 34, # 37 Exhibit 35, # 38 Exhibit 36, # 39 Exhibit 37, # 40 Exhibit 38, # 41 Exhibit 39, # 42 Exhibit 40, # 43 Exhibit 41, # 44 Exhibit 42, # 45 Exhibit 43, # 46 Exhibit 44, # 47 Exhibit 45, # 48 Exhibit 46, # 49 Exhibit 47, # 50 Exhibit 48)(Blais, Elaine) (Entered: 06/08/2021)

Entry #1 • 2021-06-08
2
Pleading / Complaint

COMPLAINT against Eli Lilly and Company Filing fee: $ 402, receipt number 0101-8809234 (Fee Status: Filing Fee paid), filed by Teva Pharmaceuticals International GmbH, Teva Pharmaceuticals USA, Inc.. (Attachments: # 1 Civil Cover Sheet, # 2 Category Form, # 3 Exhibit 1, # 4 Exhibit 2, # 5 Exhibit 3, # 6 Exhibit 4, # 7 Exhibit 5, # 8 Exhibit 6, # 9 Exhibit 7, # 10 Exhibit 8, # 11 Exhibit 9, # 12 Exhibit 10, # 13 Exhibit 11, # 14 Exhibit 12, # 15 Exhibit 13, # 16 Exhibit 14, # 17 Exhibit 15, # 18 Exhibit 16, # 19 Exhibit 17, # 20 Exhibit 18, # 21 Exhibit 19, # 22 Exhibit 20, # 23 Exhibit 21, # 24 Exhibit 22, # 25 Exhibit 23, # 26 Exhibit 24, # 27 Errata 25, # 28 Exhibit 26, # 29 Exhibit 27, # 30 Exhibit 28, # 31 Exhibit 29, # 32 Exhibit 30, # 33 Exhibit 31, # 34 Exhibit 32, # 35 Exhibit 33, # 36 Exhibit 34, # 37 Exhibit 35, # 38 Exhibit 36, # 39 Exhibit 37, # 40 Exhibit 38, # 41 Exhibit 39, # 42 Exhibit 40, # 43 Exhibit 41, # 44 Exhibit 42, # 45 Exhibit 43, # 46 Exhibit 44, # 47 Exhibit 45, # 48 Exhibit 46, # 49 Exhibit 47, # 50 Exhibit 48)(Blais, Elaine) (Entered: 06/08/2021)

Entry #1 • 2021-06-08
2
Pleading / Complaint

COMPLAINT against Eli Lilly and Company Filing fee: $ 402, receipt number 0101-8809234 (Fee Status: Filing Fee paid), filed by Teva Pharmaceuticals International GmbH, Teva Pharmaceuticals USA, Inc.. (Attachments: # 1 Civil Cover Sheet, # 2 Category Form, # 3 Exhibit 1, # 4 Exhibit 2, # 5 Exhibit 3, # 6 Exhibit 4, # 7 Exhibit 5, # 8 Exhibit 6, # 9 Exhibit 7, # 10 Exhibit 8, # 11 Exhibit 9, # 12 Exhibit 10, # 13 Exhibit 11, # 14 Exhibit 12, # 15 Exhibit 13, # 16 Exhibit 14, # 17 Exhibit 15, # 18 Exhibit 16, # 19 Exhibit 17, # 20 Exhibit 18, # 21 Exhibit 19, # 22 Exhibit 20, # 23 Exhibit 21, # 24 Exhibit 22, # 25 Exhibit 23, # 26 Exhibit 24, # 27 Errata 25, # 28 Exhibit 26, # 29 Exhibit 27, # 30 Exhibit 28, # 31 Exhibit 29, # 32 Exhibit 30, # 33 Exhibit 31, # 34 Exhibit 32, # 35 Exhibit 33, # 36 Exhibit 34, # 37 Exhibit 35, # 38 Exhibit 36, # 39 Exhibit 37, # 40 Exhibit 38, # 41 Exhibit 39, # 42 Exhibit 40, # 43 Exhibit 41, # 44 Exhibit 42, # 45 Exhibit 43, # 46 Exhibit 44, # 47 Exhibit 45, # 48 Exhibit 46, # 49 Exhibit 47, # 50 Exhibit 48)(Blais, Elaine) (Entered: 06/08/2021)

Entry #1 • 2021-06-08
2

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc